Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Horizons

The University of British Columbia

$75,000.00

Developing tools for stable-isotope tracing lipidomics that will investigate cardiac lipid metabolism

EF 2024-25

Résumé
Untargeted lipidomics by liquid chromatography – mass spectrometry (LC-MS) enables the large-scale evaluation of all lipids, while stable isotope-labelled substrates can be added to reveal changes in lipid metabolic pathways. Within a lipid subclass, the species level of identification provides the number of carbons and double bonds in a lipid; the molecular species level annotates constituent acyl groups. Lipidomics identification to the molecular species level poses a significant challenge. This is further complicated in stable isotope tracing lipidomics by the need to determine the position of a label within a lipid structure. The presence of a stable isotope label in a lipid can be detected by current methods, but there is an unmet need to develop tools to determine the label position . During diabetes, the heart exclusively relies on fatty acid (FA) uptake for energy metabolism. As a result, the FA supply exceeds the mitochondrial oxidative capacity of cardiomyocytes, contributing to lipotoxicity and myocardial dysfunction. Simultaneously evaluating the FA source (lipoprotein or non-esterified fatty acids, NEFA), composition (number of FA carbons and double bonds) and metabolic pathways that contribute to diabetic heart pathologies remains a significant challenge that may be uncovered using stable isotope-labelled lipids. Our overarching goal is to pioneer methods for identifying stable isotope-labelled lipids to the molecular species identification level using the highly complex model of cardiac lipid metabolism in diabetes. The Velenosi lab has been developing a decision-tree algorithm to identify lipids at the molecular species level; Dr. Rodrigues is a leading expert in diabetes and cardiac lipid metabolism. In Aim 1, we will extend our current decision-tree algorithm and incorporate lipid stable-isotope tracing analysis in lipidomics. In Aim 2, we apply and optimize our approach through studying the effect of diabetes on the metabolic fate of exogenous (lipoproteins, NEFA) and endogenous (lipid droplet) FAs in the heart. In Aim 3, we will develop the tools needed to characterize the metabolic fate of saturated and unsaturated FAs in healthy and diabetic hearts. Our combined expertise will contribute to the development of analysis tools that will enable the study of stable isotope-labelled lipids to the molecular species level with the capability of revealing perturbations in cardiac lipid metabolism during diabetes.
Programme
Discovery Horizons
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
DH-2024-00021
Name nom
Velenosi, Thomas
Department département
Pharmaceutical Sciences - The University of British Columbia
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
75000
Program id
DH
Program name en
Discovery Horizons
Program name fr
Horizons de la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
nan
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060107
Field of research list names en
Lipid biology (including lipidomics)
Field of research list names fr
Biologie des lipides (y compris la lipidomique)
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Developing tools for stable-isotope tracing lipidomics that will investigate cardiac lipid metabolism
Keywords
lipidomics; stable isotope tracing; lipid metabolism; mass spectrometry; diabetes; cardiovascular disease
Application summary
Untargeted lipidomics by liquid chromatography – mass spectrometry (LC-MS) enables the large-scale evaluation of all lipids, while stable isotope-labelled substrates can be added to reveal changes in lipid metabolic pathways. Within a lipid subclass, the species level of identification provides the number of carbons and double bonds in a lipid; the molecular species level annotates constituent acyl groups. Lipidomics identification to the molecular species level poses a significant challenge. This is further complicated in stable isotope tracing lipidomics by the need to determine the position of a label within a lipid structure. The presence of a stable isotope label in a lipid can be detected by current methods, but there is an unmet need to develop tools to determine the label position . During diabetes, the heart exclusively relies on fatty acid (FA) uptake for energy metabolism. As a result, the FA supply exceeds the mitochondrial oxidative capacity of cardiomyocytes, contributing to lipotoxicity and myocardial dysfunction. Simultaneously evaluating the FA source (lipoprotein or non-esterified fatty acids, NEFA), composition (number of FA carbons and double bonds) and metabolic pathways that contribute to diabetic heart pathologies remains a significant challenge that may be uncovered using stable isotope-labelled lipids. Our overarching goal is to pioneer methods for identifying stable isotope-labelled lipids to the molecular species identification level using the highly complex model of cardiac lipid metabolism in diabetes. The Velenosi lab has been developing a decision-tree algorithm to identify lipids at the molecular species level; Dr. Rodrigues is a leading expert in diabetes and cardiac lipid metabolism. In Aim 1, we will extend our current decision-tree algorithm and incorporate lipid stable-isotope tracing analysis in lipidomics. In Aim 2, we apply and optimize our approach through studying the effect of diabetes on the metabolic fate of exogenous (lipoproteins, NEFA) and endogenous (lipid droplet) FAs in the heart. In Aim 3, we will develop the tools needed to characterize the metabolic fate of saturated and unsaturated FAs in healthy and diabetic hearts. Our combined expertise will contribute to the development of analysis tools that will enable the study of stable isotope-labelled lipids to the molecular species level with the capability of revealing perturbations in cardiac lipid metabolism during diabetes.